Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Pigment”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Not applicableStudy completedNCT00564902
What this trial is testing

The Zeaxanthin and Visual Function Study

Who this might be right for
Age Related Macular DegenerationCognition Disorders
Chrysantis, Inc. 60
Very early researchStudy completedNCT03478878
What this trial is testing

Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation

Who this might be right for
Reticular Pseudodrusen (RPD)Age-Related Macular Degeneration
National Eye Institute (NEI) 9
Testing effectiveness (Phase 2)Study completedNCT01205035
What this trial is testing

High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia

Who this might be right for
Retinal DiseasesTelangiectasis
Eye Center of Northern Colorado, P.C. 6
Not applicableStudy completedNCT02332343
What this trial is testing

Sparing of the Fovea in Geographic Atrophy Progression

Who this might be right for
AtrophyGeographic AtrophyAge-related Macular Degeneration+1 more
University Hospital, Bonn 26
Post-approval studies (Phase 4)Study completedNCT04761341
What this trial is testing

FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment

Who this might be right for
Age Related Macular Degeneration
Insel Gruppe AG, University Hospital Bern 28
Not applicableNot Yet RecruitingNCT07143526
What this trial is testing

Comparison of the Sensibility of Swept Source Optical Coherence Tomography Devices in the Detection of Neovascularisation in Large Pigment Epithelium Detachments

Who this might be right for
AMD - Age-Related Macular Degeneration
University of Trieste 50
Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Not applicableStudy completedNCT01890174
What this trial is testing

Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation

Who this might be right for
Dry AMD With Macular Drusen
Carl Zeiss Meditec, Inc. 54
Testing effectiveness (Phase 2)UnknownNCT02755428
What this trial is testing

Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases

Who this might be right for
Dry Age-related Macular Degeneration
Chinese Academy of Sciences 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02286089
What this trial is testing

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Hoffmann-La Roche 24
Not applicableStudy completedNCT00718653
What this trial is testing

Effects of Antioxidants on Human Macular Pigments

Who this might be right for
Eye Health
National Eye Institute (NEI) 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07418177
What this trial is testing

Study in Human iPSCs-derived RPE Cells Transplantation for Late-Stage AMD

Who this might be right for
AMD - Age-Related Macular Degeneration
The First Affiliated Hospital with Nanjing Medical University 9
Testing effectiveness (Phase 2)UnknownNCT02590692
What this trial is testing

Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

Who this might be right for
Dry Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 16
Not applicableLooking for participantsNCT06491615
What this trial is testing

National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

Who this might be right for
Inherited Ophthalmic DiseasesHypopigmentation DisorderCorneal Dystrophy+4 more
National Eye Institute (NEI) 1,000
Not applicableUnknownNCT01521819
What this trial is testing

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

Who this might be right for
Retinal Pigment Epithelial Detachment With VascularizationAge Related Macular Degeneration
Oraya Therapeutics, Inc. 12
Not applicableStudy completedNCT02113254
What this trial is testing

Study of the Macular Pigment by the Consumption of Corn With Strong Content in Zeaxanthine

Who this might be right for
Age Macular Degeneration
University Hospital, Bordeaux 9
Not applicableStudy completedNCT01354093
What this trial is testing

The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

Who this might be right for
Idiopathic Juxtafoveal Telangiectasia
Paul S. Bernstein 8
Post-approval studies (Phase 4)Study completedNCT02142296
What this trial is testing

Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)

Who this might be right for
Retinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 37
Testing effectiveness (Phase 2)Ended earlyNCT03959592
What this trial is testing

Macular Pigment and Visual Performance in Glaucoma Patients

Who this might be right for
Glaucoma
Felipe Medeiros, MD 8
Post-approval studies (Phase 4)Study completedNCT01628354
What this trial is testing

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationRetinal Pigment Epithelial Detachment
University of Melbourne 49
Load More Results